HAL Id: hal-02032944
https://hal.sorbonne-universite.fr/hal-02032944
Submitted on 20 Feb 2019
HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Autoantibodies Against C3b-Functional Consequences and Disease Relevance
Vasil Vasilev, Maria Radanova, Valentin Lazarov, Marie-Agnès Dragon-Durey, Veronique Fremeaux-Bacchi, Lubka Roumenina
To cite this version:
Vasil Vasilev, Maria Radanova, Valentin Lazarov, Marie-Agnès Dragon-Durey, Veronique Fremeaux-
Bacchi, et al.. Autoantibodies Against C3b-Functional Consequences and Disease Relevance. Frontiers
in Immunology, Frontiers, 2019, 10, pp.64. �10.3389/fimmu.2019.00064�. �hal-02032944�
Edited by:
Alexandre Belot, Claude Bernard University Lyon 1, France
Reviewed by:
Josh Thurman, University of Colorado, United States Marie Nathalie Sarda, Université de Lyon, France
*Correspondence:
Lubka T. Roumenina lubka.roumenina@crc.jussieu.fr
†
These authors have contributed equally to this work
Specialty section:
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
Received: 02 November 2018 Accepted: 11 January 2019 Published: 29 January 2019
Citation:
Vasilev VV, Radanova M, Lazarov VJ, Dragon-Durey M-A, Fremeaux-Bacchi V and Roumenina LT (2019) Autoantibodies Against C3b—Functional Consequences and Disease Relevance. Front. Immunol. 10:64.
doi: 10.3389/fimmu.2019.00064
Autoantibodies Against
C3b—Functional Consequences and Disease Relevance
Vasil V. Vasilev
1†, Maria Radanova
2†, Valentin J. Lazarov
1, Marie-Agnes Dragon-Durey
3,4,5,6, Veronique Fremeaux-Bacchi
3,4,5,6and Lubka T. Roumenina
4,5,6*
1
Nephrology Clinic, University Hospital “Tsaritsa Yoanna-ISUL,” Medical University–Sofia, Sofia, Bulgaria,
2Department of Biochemistry, Molecular Medicine and Nutrigenomics, Medical University Varna, Varna, Bulgaria,
3Assistance
Publique–Hôpitaux de Paris, Service d’Immunologie Biologique, Hôpital Européen Georges Pompidou, Paris, France,
4